Gujarat Kidney And Super Speciality Limited

Healthcare · Healthcare Services

NSE: GKSL BSE: 544666
₹179.05
▲ 3.16 (1.80%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
77/100
Strong
Valuation
5/100
Expensive
Momentum
31/100
Neutral

QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,412 Cr
PE (TTM)
133.6
Industry median 50.2 (44 companies)
Price to Book
5.5
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
5.44%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
51.2
Relative return vs Sector, qtr %
39.3
Free Cash Flow
₹-15 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
3.76
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.06
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
8.13
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
22.04%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
32.50%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
29.48%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 3 met
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.06)
  • Yes Net cash flow for the latest year is positive

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Value and momentum

1 of 4 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.8%
Low 176.3800 · High 184.4000
1W return
0.8%
Low 169.9300 · High 185.8000
1M return
13.2%
Low 156.6600 · High 186.9900
52W return
Data unavailable.
Low 98.3600 · High 186.9900
Lifetime High ₹183.2100 (Sept. 21, 2026)
Lifetime Low ₹99.3600 (Jan. 23, 2026)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish0
5D
176.9
10D
176.1
20D
172.4
50D
159.5
100D
145.8

Delivery and volume

Day avg. delivery
5.6%
Week avg. delivery
8.4%
Month avg. delivery
15.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

179.94
Pivot
First resistance183.51
Second resistance187.96
Third resistance191.53
First support175.49
Second support171.92
Third support167.47
Day RSI61.7
Day MFI44.3
Day MACD6.04
Day MACD signal7.24

Beta

1M1.51
3M0.29
1Y0.45
3Y0.45

Price change analysis

↑ 13.2%
Over 1 Month
LowHigh
156.66186.99
↑ 36.5%
Over 3 Months
LowHigh
126.36186.99
↑ 73.3%
Over 6 Months
LowHigh
101.99186.99
—
Over 1 Year
LowHigh
98.36186.99
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹9 Cr
Net profit (June 30, 2026)
₹2 Cr
Basic EPS (June 30, 2026)
₹0.2600

Ranks #32 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter71.45%
  • FII/FPI4.88%
  • Other DII0.56%
  • Public23.11%

Largest holders

NameCategoryShares %Shares
Pragnesh Yashwantsinh BharpodaPromoter38.1600%30084250
Anitaben NayakPromoter11.1000%8750000
Yashwantsingh Motisingh BharpodaPromoter11.1000%8750000
Bhartiben Pragnesh BharpodaPromoter11.1000%8749475
Craft Emerging Market Fund Pcc-Citadel Capital FundPublic1.6700%1315926

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 71.45% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings were unchanged at 4.88% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
1 Oct 2026 PRIYAL BOHRA Bulk Sell 399,546 193.4100 NSE
1 Oct 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 1,030,937 199.9300 NSE
1 Oct 2026 GRT STRATEGIC VENTURES LLP Bulk Sell 570,047 198.9300 NSE
1 Oct 2026 IRAGE BROKING SERVICES LLP Bulk Sell 420,664 199.5600 NSE
1 Oct 2026 QE SECURITIES LLP Bulk Sell 933,215 197.6800 NSE
1 Oct 2026 HRTI PRIVATE LIMITED Bulk Sell 563,833 197.4900 NSE
1 Oct 2026 JUNOMONETA FINSOL PRIVATE LIMITED Bulk Sell 1,502,241 199.1000 NSE
1 Oct 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Sell 1,498,972 200.0400 NSE
1 Oct 2026 IMC INDIA SECURITIES PRIVATE LIMITED Bulk Sell 444,824 200.9900 NSE
1 Oct 2026 ALPHAGREP SECURITIES PRIVATE LIMITED Bulk Sell 613,390 198.5300 NSE

All bulk and block deals →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
14 Aug 2026 Financial Results Yes
28 May 2026 Financial Results Yes
14 Feb 2026 Financial Results/Other business matters Yes
13 Feb 2026 Financial Results/Other business matters Yes

Corporate Announcements

All 67 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 AGM/EGM Gujarat Kidney and Super Speciality Ltd - 544666 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 Shareholders meeting Gujarat Kidney And Super Speciality Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026. Further, the company has informed the Exchange regarding voting results.
28 Sep 2026 AGM/EGM Gujarat Kidney and Super Speciality Ltd - 544666 - Shareholder Meeting / Postal Ballot-Outcome of AGM
28 Sep 2026 Shareholders meeting Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026
26 Sep 2026 Trading Window Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
19 Sep 2026 Others Gujarat Kidney and Super Speciality Ltd - 544666 - Reg. 34 (1) Annual Report.
4 Sep 2026 Copy of Newspaper Publication Gujarat Kidney And Super Speciality Limited has informed the Exchange about Copy of Newspaper Publication about mailing Annual report
3 Sep 2026 AGM/EGM Gujarat Kidney and Super Speciality Ltd - 544666 - AGM To Be Held On 28-09-2026
3 Sep 2026 Shareholders meeting Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026
1 Sep 2026 General Updates Gujarat Kidney And Super Speciality Limited has informed the Exchange about Pre advertisement for Notice of 7th AGM

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (22.0%)
  • Low financial leverage (Debt/Equity 0.06)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (133.6) -- priced for continued strong execution

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Gujarat Kidney And Super Speciality Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.